Publications:

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

The Lancet. Oncology

Mossé, Yael P YP; Lim, Megan S MS; Voss, Stephan D SD; Wilner, Keith K; Ruffner, Katherine K; Laliberte, Julie J; Rolland, Delphine D; Balis, Frank M FM; Maris, John M JM; Weigel, Brenda J BJ; Ingle, Ashish M AM; Ahern, Charlotte C; Adamson, Peter C PC; Blaney, Susan M SM

Publication Date: 2013-05

Variant appearance in text: ALK: A3=

PubMed Link: 23598171

Variant Present in the following documents:

• Main text

View BVdb publication page